![EU Competition on Twitter: "#EUAntritust Aspen proposes 73% price reduction for six off-patent cancer medicines to remove 🇪🇺 Commission's excessive pricing concerns ⬇️ https://t.co/WRictPhYGP https://t.co/gN0RvOtzqE" / Twitter EU Competition on Twitter: "#EUAntritust Aspen proposes 73% price reduction for six off-patent cancer medicines to remove 🇪🇺 Commission's excessive pricing concerns ⬇️ https://t.co/WRictPhYGP https://t.co/gN0RvOtzqE" / Twitter](https://pbs.twimg.com/media/Ec4LiPnX0AAfm4z.jpg)
EU Competition on Twitter: "#EUAntritust Aspen proposes 73% price reduction for six off-patent cancer medicines to remove 🇪🇺 Commission's excessive pricing concerns ⬇️ https://t.co/WRictPhYGP https://t.co/gN0RvOtzqE" / Twitter
![EU Competition on Twitter: "#EUAntitrust Commission accepts commitments by Aspen to reduce prices for six off-patent cancer medicines by 73% addressing excessive pricing concerns https://t.co/TWOSlrzpgA https://t.co/SHNfB9mks6" / Twitter EU Competition on Twitter: "#EUAntitrust Commission accepts commitments by Aspen to reduce prices for six off-patent cancer medicines by 73% addressing excessive pricing concerns https://t.co/TWOSlrzpgA https://t.co/SHNfB9mks6" / Twitter](https://pbs.twimg.com/media/Et3QQnsXAAMF8FA.jpg)
EU Competition on Twitter: "#EUAntitrust Commission accepts commitments by Aspen to reduce prices for six off-patent cancer medicines by 73% addressing excessive pricing concerns https://t.co/TWOSlrzpgA https://t.co/SHNfB9mks6" / Twitter
![The Commission Accepts Commitments Offered by Aspen in Its First Decision on Excessive Pricing in the Pharmaceutical Sector | Cleary Antitrust Watch The Commission Accepts Commitments Offered by Aspen in Its First Decision on Excessive Pricing in the Pharmaceutical Sector | Cleary Antitrust Watch](https://www.clearyantitrustwatch.com/wp-content/uploads/sites/816/2021/10/Aspen.png)